NCT06258785 - Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Postoperative Urinary RetentionSacrospinous Vaginal Vault SuspensionReconstructive Pelvic Surgery

Interventions

DRUG

Tizanidine

Tizanidine 2mg will be given preoperatively prior to scheduled sacrospinous ligament suspension

Trial Locations (1)

RECRUITING

NorthShore University Health System, Skokie